{"id":101,"date":"2012-08-31T10:57:32","date_gmt":"2012-08-31T09:57:32","guid":{"rendered":"http:\/\/www.micklefieldlab.chemistry.manchester.ac.uk\/?page_id=101"},"modified":"2018-05-22T13:58:33","modified_gmt":"2018-05-22T12:58:33","slug":"dr-mark-thompson","status":"publish","type":"page","link":"https:\/\/www.micklefieldlab.chemistry.manchester.ac.uk\/?page_id=101","title":{"rendered":"Dr. Mark Thompson"},"content":{"rendered":"

\"\"<\/a><\/strong><\/p>\n

Mark Thompson<\/strong> obtained his BSc. in Biochemistry from the University of York in 2006 which included a year working in industry within the Pharmacokinetics Dynamics and Metabolism department at Pfizer. After graduation he remained at the University of York completing a PhD in Chemistry in 2009, investigating biocatalytic routes for the production of commercially desirable monoterpene alcohols. Following this, from 2010-2011 he worked on a Post-doctoral position at the University of Greifswald (Germany). During this time in the Department of Biotechnology & Enzyme Catalysis, his research focussed on enzymes including Baeyer Villiger monooxygenases, esterases, and phenol oxidases. Work involved the targeted discovery of new biocatalysts and enhancement of catalytic properties via protein engineering, together with assay development and applied microbiology. After joining the Micklefield group in 2011 his current research interests are centred on the engineering of a number of different enzymes for improved commercial application.<\/p>\n

Publications:<\/span><\/p>\n